Reserve Bank of India (RBI) Governor Shaktikanta Das-chaired Monetary Policy Committee (MPC) raised the repo rate by 50 basis points (bps) to 5.40 percent.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.